Impact of allopurinol use on urate concentration and cardiovascular outcome

Effect of high-dose allopurinol on exercise in patients with chronic stable angina: a randomised, placebo controlled crossover trial

(2010) Awsan Noman et al.   LANCET

Serum uric acid level as an independent risk factor for all-cause, cardiovascular, and ischemic stroke mortality: A chinese cohort study

(2009) Jiunn-Horng Chen et al.   ARTHRITIS AND RHEUMATISM

Elevated Serum Uric Acid Concentrations Independently Predict Cardiovascular Mortality in Type 2 Diabetic Patients

(2009) G. Zoppini et al.   DIABETES CARE

Association between allopurinol and mortality in heart failure patients: a long-term follow-up study

(2009) L. Wei et al.   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

Gout

(2009) Pascal Richette et al.   LANCET

Allopurinol and mortality in hyperuricaemic patients

(2009) A. J. Luk et al.   RHEUMATOLOGY

A randomised controlled trial on the efficacy and tolerability with dose escalation of allopurinol 300-600 mg/day versus benzbromarone 100-200 mg/day in patients with gout

(2008) M K Reinders et al.   ANNALS OF THE RHEUMATIC DISEASES

Effect of Allopurinol on Blood Pressure of Adolescents With Newly Diagnosed Essential Hypertension

(2008) Daniel I. Feig et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Allopurinol Use Yields Potentially Beneficial Effects on Inflammatory Indices in Those With Recent Ischemic Stroke

(2008) Scott W. Muir et al.   STROKE